Anthem BioSciences (NSE:ANTHEM, BOM:544449) has an average rating of buy and mean price target of 879.43 Indian rupees, according to analysts polled by FactSet.
What else is happening in Asia?
Asia
Winbond Electronics to Procure Machinery Equipment for NT$2.3 Billion; Shares Rally 10%
Winbond Electronics (TPE:2344) will procure machinery equipment worth about NT$2.3 billion from Applied Materials, according to a Thursday Taiwan Exchange filing.Shares jumped about 10% in Friday's late morning trade.The equipment will be used for for production purposes, it said.
TPE:2344
Asia
CapitaLand Ascendas REIT Launches SG$1.4 Billion Life Sciences Cluster
CapitaLand Ascendas REIT (SGX:A17U) along with CapitaLand Development, launched Geneo, a SG$1.4 billion life sciences and innovation hub at Singapore Science Park, according to a Friday filing with the Singapore Exchange.Geneo spans across an area of 180,600 square meters and comprises three properties, which include laboratories and business park workspaces.
SGX:A17U
Asia
China Bohai Bank Completes 9 Billion Yuan Tier 2 Bond Issue
China Bohai Bank (HKG:9668) completed the issuance of 9 billion yuan in tier 2 capital bonds in China's interbank bond market, according to a Thursday Hong Kong bourse filing.Shares of the lender were up more than 1% in late morning trade on Friday.The bonds are 10-year fixed-rate notes with an issuer redemption option at the end of the fifth year and carry a coupon rate of 2.10%.The bank said proceeds from the issuance will be used entirely to replenish its tier 2 capital.
HKG:9668